Programmed Cell Senescence during Mammalian Embryonic Development  by Muñoz-Espín, Daniel et al.
Programmed Cell Senescence
during Mammalian Embryonic Development
Daniel Mun˜oz-Espı´n,1 Marta Can˜amero,2 Antonio Maraver,1 Gonzalo Go´mez-Lo´pez,3 Julio Contreras,4,5,6
Silvia Murillo-Cuesta,5,6 Alfonso Rodrı´guez-Baeza,7 Isabel Varela-Nieto,5,6 Jesu´s Ruberte,8 Manuel Collado,1,9
and Manuel Serrano1,*
1Tumor Suppression Group
2Histopathology Unit
3Bioinformatics Unit
Spanish National Cancer Research Center (CNIO), Madrid E28029, Spain
4Department of Anatomy, School of Veterinary Medicine, Universidad Complutense de Madrid, Madrid E28040, Spain
5Instituto de Investigaciones Biome´dicas Alberto Sols, CSIC-UAM, Madrid E28029, Spain
6Centre for Biomedical Network Research on Rare Diseases (CIBERER), Valencia E46010, Spain
7Departament de Cie`ncies Morfolo`giques, Facultat de Medicina
8Center for Animal Biotechnology and Gene Therapy (CBATEG), Department of Anatomy and Animal Health, School of Veterinary Medicine
Universitat Auto`noma de Barcelona, Bellaterra E08193, Spain
9Present address: Instituto de Investigacio´n Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de
Compostela (CHUS), SERGAS, Santiago de Compostela E15706, Spain
*Correspondence: mserrano@cnio.es
http://dx.doi.org/10.1016/j.cell.2013.10.019SUMMARY
Cellular senescence disables proliferation in
damaged cells, and it is relevant for cancer and
aging. Here, we show that senescence occurs dur-
ing mammalian embryonic development at multiple
locations, including the mesonephros and the
endolymphatic sac of the inner ear, which we have
analyzed in detail. Mechanistically, senescence in
both structures is strictly dependent on p21, but in-
dependent of DNA damage, p53, or other cell-cycle
inhibitors, and it is regulated by the TGF-b/SMAD
and PI3K/FOXO pathways. Developmentally pro-
grammed senescence is followed by macrophage
infiltration, clearance of senescent cells, and tissue
remodeling. Loss of senescence due to the absence
of p21 is partially compensated by apoptosis but still
results in detectable developmental abnormalities.
Importantly, the mesonephros and endolymphatic
sac of human embryos also show evidence of senes-
cence. We conclude that the role of developmentally
programmed senescence is to promote tissue re-
modeling and propose that this is the evolutionary
origin of damage-induced senescence.
INTRODUCTION
Cellular senescence is defined as a stable cell-cycle arrest eli-
cited in response to multiple types of damage, such as intense
oncogenic signaling, DNA damage, and telomere loss (Campisi
and d’Adda di Fagagna, 2007; Collado et al., 2007). Senescent
cells are found in association with pathological situations, most1104 Cell 155, 1104–1118, November 21, 2013 ª2013 Elsevier Inc.notably within tumors and in some aged tissues (Campisi and
d’Adda di Fagagna, 2007; Collado et al., 2007). The tumor sup-
pressors p16INK4a (abbreviated as p16), p19ARF, p53, and RB
are critical for the establishment of senescence in most experi-
mental settings (Campisi and d’Adda di Fagagna, 2007; Collado
et al., 2007), although other senescence mediators have been
identified (Gorgoulis and Halazonetis, 2010). For instance,
cyclin-dependent kinase inhibitors p21 and p27 also contribute
to senescent phenotypes (Collado and Serrano, 2010). In addi-
tion, senescent cells secrete a number of extracellular factors,
including transforming growth factor b (TGF-b), IGF1-binding
proteins, and inflammatory cytokines, that can reinforce and
propagate senescence in an autocrine and paracrine manner
(Acosta et al., 2013; Kuilman and Peeper, 2009). The senes-
cence-associated secretory phenotype (SASP) can also evoke
a local inflammatory response with complex effects, including
the elimination of senescent cells by phagocytosis, thus leading
to tissue remodeling and damage resolution (Freund et al.,
2010; Hoenicke and Zender, 2012; Krizhanovsky et al., 2008).
Together with senescence, apoptosis is the other main cellular
response to damage, and both processes can share common
triggers, such as DNA damage or oncogenic stress, and com-
mon mediators, most notably p53 (Campisi and d’Adda di Faga-
gna, 2007; Collado et al., 2007; Vousden and Prives, 2009).
Apoptosis in response to errors, insults, or pathological situa-
tions has been referred to as nonprogrammed cell death to
reflect its accidental nature (Kourtis and Tavernarakis, 2007).
Interestingly, apoptosis also plays an important role during
animal development, where it occurs in a well-defined manner
in response to developmental cues, and it is classically referred
to as developmentally programmed cell death (Conradt, 2009;
Fuchs and Steller, 2011; Kourtis and Tavernarakis, 2007).
We hypothesized that cellular senescence, like apoptosis,
could also participate in embryonic development, i.e., in a
developmentally programmed manner. We report here the
existence of widespread developmental senescence during
mammalian development, and we focus on two embryonic
structures, the mesonephros and the endolymphatic sac of the
inner ear.
We took note of a previous report showing senescence-asso-
ciated b-galactosidase (SAbG) activity in the regressing meso-
nephros of birds (Nacher et al., 2006), although this observation
was not further characterized. SAbG is the most widely used
assay to detect senescence both in vitro and in vivo (Collado
and Serrano, 2006; Dimri et al., 1995), and it is based on the
increased lysosomal content of senescent cells (Kurz et al.,
2000). In mammals, the mesonephros is an elongated structure,
adjacent to the gonads, and longitudinally crossed by the meso-
nephric or Wolffian ducts, from which numerous lateral tubules
emerge (Sainio, 2003; Vazquez et al., 1998). The mesonephros
functions as a transitory embryonic kidney before the maturation
of the definitive kidney, or metanephros, and then it essentially
disappears (Davidson, 2008).
We have also focused on the endolymphatic sac of the inner
ear because we found that its SAbG activity is particularly
prominent. The function of the endolymphatic sac is to collect
and filtrate the endolymph of the cochlear and vestibular
canals, which are involved in hearing and balance, respectively
(Hultcrantz et al., 1987; Lo et al., 1997).
Here, we present a detailed analysis of developmentally pro-
grammed senescence at the mesonephros and at the endolym-
phatic sac, including the genetic identification of mediators
and regulatory pathways, the manipulation of the senescence
program with chemical agents, the analysis of clearance mech-
anisms and compensatory processes, and finally, the morpho-
logical consequences of abrogating programmed senescence.
RESULTS
Developmentally Programmed Senescence in
Whole-Mount Embryos
We began by performing exploratory SAbG stainings in whole-
mount mouse embryos at different developmental stages. Two
intense SAbG signals were reproducibly observed near the ear
canals from embryonic day 12.5 (E12.5) to E14.5 (Figure 1A, first
picture from the left), which upon further analysis turned out to
correspond to the endolymphatic sacs (abbreviated ES) (see
below). A symmetric pattern of SAbG staining was also observed
in the posterior cranium that corresponds to the closing neural
tube (Figure 1A, first picture). SAbG signal was also found in
the apical ectodermal ridge (AER) of the limbs at E11.5 (Fig-
ure 1A, second picture) and was at later times concentrated at
the bottom of the regressing interdigital webs (Figure 1A, third
picture). Moreover, SAbG staining was also obvious around the
vibrissae (below the eye) (Figure 1A, fourth picture). Other sites
positive for SAbG are listed separately (Table S1 available
online). Similar findings are reported in the accompanying paper
(Storer et al., 2013). Based on a previous report of SAbG activity
in the mesonephros of the quail (Nacher et al., 2006), we
dissected the gonad-mesonephros complex of mouse embryos
and performed whole-mount staining, revealing a clear positive
SAbG signal in the mesonephric tubules (Figure 1A, fifth picture).CTherefore, cellular senescence, defined at this point on the basis
of SAbG activity, is a frequent finding in whole-mount embryos.
Developmentally Programmed Senescence in the
Mesonephric Tubules and Endolymphatic Sac
We decided to focus on the mesonephric tubules (Figure S1A)
due to the evolutionary conservation of senescence in this organ
from birds to mammals and on the endolymphatic sac (Fig-
ure S1B) because of its intense SAbG staining in whole-mount
embryos. The involution of the mesonephros begins at E14.5,
and within 24 hr, almost all the mesonephric tubules disappear
in a caudal-to-apical direction (Davidson, 2008; Vazquez et al.,
1998). Fresh whole-mount embryos at different developmental
stages were subjected to SAbG staining and then were pro-
cessed for paraffin inclusion, sectioned, and, when indicated,
stained by immunohistochemistry. At day E11.5, the meso-
nephric tubules had no SAbG activity and were highly positive
for the proliferation marker Ki67 (Figure 1B). However, from
E12.5 to E14.5, SAbG activity was clearly detectable, and Ki67
staining was progressively reduced. Finally, at E15.5, most of
the mesonephric tubules had disappeared and hardly, if any,
SAbG staining was observed. Therefore, there is a strong
association between SAbG activity and absence of proliferation,
which together constitute a hallmark of senescence.
A similar pattern and kinetics were observed in the endolym-
phatic sac (Figure 1C). However, it is important to note that, in
contrast to the mesonephros, in the case of the endolymphatic
sac there is no regression. Previous investigators have reported
that a minor fraction of cells within the endolymphatic sac un-
dergo a rapid expansion beginning at E14.5 (Kim and Wange-
mann, 2011), and, as we will show further below, this is the
most plausible explanation for Ki67 positivity at E15.5 in this
organ.
The intensity of the SAbG signal in the E14.5 endolymphatic
sac was noticeably higher than in the mesonephros, and we
wondered whether this was due, at least in part, to the different
accessibility of the b-galactosidase substrate (X-Gal) to the two
structures when performing whole-mount staining. To address
this, unstained frozen embryos embedded in OCT were serially
sectioned, and the relevant sections containing the meso-
nephros and the endolymphatic sac were stained in parallel for
SAbG (Figure 1D). Interestingly, under equal staining conditions,
the intensity of the SAbG signal was comparable in both struc-
tures. This also indicates that the reduced accessibility of
X-Gal to internal organs, such as the mesonephros, significantly
decreases the intensity of the SAbG signal in whole-mount stain-
ing of embryos.
To further document senescence in the mesonephric tubules
andendolymphatic sac,weusedmarkers of senescence-associ-
ated heterochromatin (Narita et al., 2003) and observed that
epithelial cells from both structures at E14.5 were positive for
HP1g (Figure 1E) andH3K9me3 (Figure S1C), whereas surround-
ing stromal cellswere negative. In contrast, at E11.5, the epithelia
of the mesonephric tubules and endolymphatic sac were nega-
tive or weakly positive for H3K9me3 (Figure S1C), thus following
the same pattern as the SAbG staining. We also wondered
whether senescent cells were arrested at G1 (or alternatively
at G2), and for this, we stained with the centrosomal markerell 155, 1104–1118, November 21, 2013 ª2013 Elsevier Inc. 1105
Figure 1. Programmed Senescence Occurs
during Mouse Embryonic Development
(A) Examples of senescent structures after embryo
whole-mount SAbG staining at the indicated stages.
ES, endolymphatic sac; AER, apical ectodermal
ridge.
(B) Whole-mount SAbG staining and Ki67 immuno-
histochemistry of mesonephric tubules at the indi-
cated stages. The percentages of Ki67-positive cells
in the mesonephric tubules are shown (E11.5, n = 4;
E12.5, n = 3; E13.5, n = 3; E14.5, n = 7).
(C) Whole-mount SAbG staining and Ki67 immuno-
histochemistry of the endolymphatic sac at the indi-
cated stages. The percentages of Ki67-positive cells
at the endolymphatic sac are shown (E11.5, n = 3;
E12.5, n = 5; E13.5, n = 5; E14.5, n = 10; E15.5, n = 4).
(D) Cryosections containing mesonephric tubules
(left) and endolymphatic sac (right) stained with
SAbG.
(E) HP1g (red) immunofluorescence of a meso-
nephric tubule (left) and endolymphatic sac (right).
The basal lamina of the two epithelia is indicated with
a dotted white line. Nuclei were stained with DAPI
(blue).
All samples correspond to WT embryos. SAbG and
HP1g stainings were performed in at least five
embryos, obtaining the same result in all cases. In (B)
and (C), values are expressed as mean ± SD, and
statistical significance is relative to E11.5 embryos
assessed by the two-tailed Student’s t test: ***p <
0.001; n.s. (not significant).
See also Figure S1 and Table S1.
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Figure 2. Expression of Cell-Cycle Inhibi-
tors in the Mesonephric Tubules and
Endolymphatic Sac
(A) Mesonephric tubules stained for p53, p21, p27,
or p15. The graphs show the percentages of
positively stained cells in the epithelia of the
mesonephric tubules at E11.5 and E14.5. Dotted
black lines, at E11.5, separate the mesonephros
(upper part) from the gonad (lower part).
(B) Endolymphatic sacs stained as in (A). The
graphs show the percentages of positively stained
cells in the endolymphatic sac epithelia at E11.5
and E14.5. In the case of p15 staining, the graph
shows the percentage of positively stained cells
at both epithelial (sac) and perisacular (perisac)
regions at E11.5 and E14.5. The picture exhibiting
p15 staining at E14.5 corresponds to an embryo
subjected to whole-mount SAbG staining to
differentiate the epithelium from the perisacular
region.
All samples correspond to WT embryos. Values
are expressed as mean ± SD, and statistical
significance was assessed by the two-tailed
Student’s t test: *p < 0.05; ***p < 0.001; n.s. (not
significant); the total number of embryos analyzed
is indicated in each graph (n).
See also Figure S2.pericentrin. In both structures, we observed a single centrosome
signalper cell,which is indicativeofG1-phasearrest (FigureS1D).
Finally, the mesonephric tubules and endolymphatic sac hadCell 155, 1104–1118, Nonegligible gH2AX levels that were even
lower than those in the surrounding
stroma (Figure S1E), thus indicating that
DNA damage is not associated with
senescence in these structures.
In summary, we document the occur-
rence of developmentally programmed
senescence in the mesonephric tubules
and in the endolymphatic sac, character-
ized by SAbG activity, senescence-asso-
ciated heterochromatin markers, and
absence of proliferation due to G1-phase
arrest.
Expression of Senescence
Mediators in the Mesonephric
Tubules and Endolymphatic Sac
We also examined the expression of the
most relevant mediators of senescence.
Sections of E11.5 (low SAbG) and E14.5
(high SAbG) embryos were stained to
detect p53, p21, p27, p15, p19ARF, and
p16 (Figures 2A, 2B, and S2A). Positive,
albeit weak, staining of p53 was detected
in the epithelia of mesonephric tubules
and endolymphatic sac, but its levels
did not increase from E11.5 to E14.5. In
contrast, staining for p21, p27, or p15was significantly increased from E11.5 to E14.5 (Figures 2A
and 2B). In the case of p27, expression at E14.5 was observed
in the epithelia and in the surrounding stroma; and, in the casevember 21, 2013 ª2013 Elsevier Inc. 1107
(legend on next page)
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of p15, expression wasmore prominent in the perisacular stroma
of the endolymphatic sac rather than in the epithelium. No evi-
dence of expression was obtained for p19ARF or p16 in the
mesonephros or endolymphatic sac (Figure S2A).
Developmentally Programmed Senescence Requires
p21 Independently of p53
The functional relevance of the senescence mediators examined
above was tested genetically. Despite the almost universal rele-
vance of p53 in senescence (Campisi and d’Adda di Fagagna,
2007; Collado et al., 2007), the mesonephric tubules and endo-
lymphatic sac of p53 null embryos presented similar levels of
SAbG activity and Ki67-negative cells as did wild-type (WT) em-
bryos (Figures3Aand3B). Incontrast, theseepitheliawerealmost
completely devoid of SAbG activity, andmost cells were positive
for Ki67 in p21 null embryos (Figures 3A, 3B, and S2B). Also, the
levels of SAbGactivity at the endolymphatic sac ofp21-heterozy-
gous embryos were intermediate between those in WT and p21
null embryos (Figure S2C). These observations indicate that
senescence is dependent on p21, but independent of p53.
Accordingly, p21 levels were similar in both epithelial structures
regardless of the status of p53 (Figures 3A and 3B). Remarkably,
H3K9me3 andHP1g immunofluorescence signalswere absent in
p21nullmesonephric tubules andendolymphatic sac,whereas in
WT embryos, most of the cells positive for H3K9me3 and HP1g
were also positive for p21 (Figures 3C and 3D). Moreover, in WT
embryos, the levels of p21 increased progressively at both struc-
tures from E11.5 to E14.5 (Figure S2D), in a manner similar to that
of the SAbG activity (Figures 1B and 1C).
We also explored the possible role of the DNA-damage-
signaling kinases ATM and ATR, which induce senescence by
activating p53 (Halazonetis et al., 2008; Toledo et al., 2008).
For this, we examined the mesonephros and endolymphatic
sac of Atm null embryos and Atr-Seckel embryos (the latter
having a severe, but viable, reduction in Atr activity). However,
none of them showed alterations in SAbG activity (Figure S3A),
which is in agreement with the absence of detectable DNA
damage in the senescent mesonephros and endolymphatic
sac (see Figure S1E). Aside from DNA-damage signaling,
p19ARF is another main activator of p53 (Collado et al., 2007).
Thus, we examined p16/p19ARF null mice (Figure S3B) and
also double-transgenic mice carrying one extra gene copy of
the p15/p16/p19ARF locus and one extra gene copy of p53 (Fig-
ure S3C). However, none of these embryos presented alterationsFigure 3. Developmentally Programmed Senescence at the Mesoneph
(A) Mesonephric tubules of E14.5 murine embryos of the indicated genotypes sta
subjected to staining of Ki67 (left and central panels), or stained only for p21 (righ
positive cells, and p21-positive cells in the epithelia.
(B) Endolymphatic sacs stained and quantified as in (A).
(C) Mesonephric tubules at E14.5 stained for p21 (green), trimethylated lysine 9
with DAPI (blue).
(D) Endolymphatic sacs stained as in (C).
(E) Human embryos (9weeks into pregnancy, n = 2) were stained for Ki67 and p2
show details. MD, Mullerian duct; WD, Wolffian duct; MT, mesonephric tubules.
(F) Human endolymphatic sac stained as in (E). Closed and open arrowheads ind
Values are expressed as mean ± SD; the total number of embryos analyzed is ind
two-tailed Student’s t test: **p < 0.01; ***p < 0.001.
See also Figure S3.
Cin SAbG activity or Ki67 staining in themesonephros or endolym-
phatic sac. These observations discard a role for p19ARF and
p16 and are in agreement with their negative staining (see Fig-
ure S2A). The INK4 family of cell-cycle inhibitors (which includes
p16INK4a, p15INK4b, p18INK4c, and p19INK4d) induces cell-cycle
arrest by binding and inhibiting the cell-cycle kinases CDK4
and CDK6. To test the role of the INK4/CDK4,6 pathway, we
analyzed mice carrying homozygous point mutations in CDK4
(mutation R24C) and CDK6 (mutation R31C) that prevent
their binding to all the INK4 family members, thereby rendering
them insensitive to these cell-cycle inhibitors. However,
embryos Cdk4-R24C;Cdk6-R31C presented normal levels of
SAbG activity and absence of Ki67 in the mesonephros and
endolymphatic sac (Figure S3D). Finally, we also observed that
p27 null embryos presented normal levels of SAbG activity and
Ki67-negative cells in both structures (Figure S3E).
To extend the concept of programmed senescence to human
development, we examined human embryo samples at a stage
when the mesonephros is regressing (16–17 mm crown-rump
length, 9 weeks pregnancy). Interestingly, the mesonephric
tubules were negative for Ki67 and strongly positive for p21,
whereas the Mullerian duct (an external duct attached to the
mesonephros) and the definitive kidney tubules were positive
for Ki67 and weak or negative for p21 (Figure 3E). A similar
situation was encountered in the endolymphatic sac, with few
Ki67-positive cells and abundant p21-positive cells (Figure 3F).
We conclude that developmentally programmed senescence
in the mesonephros and endolymphatic sac is mediated by
p21 in a p53-independent manner. Moreover, we exclude a
relevant role for the DNA-damage-signaling kinases ATM and
ATR, the p53 activator p19ARF, the p16 and p15 cell-cycle inhib-
itors, and, more generally, the INK4/CDK4,6 pathway, and we
also exclude the cell-cycle inhibitor p27. Finally, we provide
evidence for senescence features in the human mesonephros
and endolymphatic sac.
Role of the TGF-b/SMAD Pathway in Developmentally
Programmed Senescence
To gain insight into the pathways that could regulate senescence
during development, we microdissected the mesonephric tu-
bules of WT (n = 5) and p21 null (n = 3) embryos at E14.5, and
the obtained RNA was used to hybridize DNAmicroarrays. Anal-
ysis of the results with gene set enrichment analysis (GSEA) re-
vealed that p21 null mesonephric tubules have significantlyric Tubules and Endolymphatic Sac Depends on p21
ined for SAbG and, subsequently, counterstained with nuclear fast red (NFR),
t panels), as indicated. The graphs show the percentage of blue surface, Ki67-
of histone 3 (H3K9m3) (red), or HP1g (red), as indicated. Nuclei were stained
1. Left panels show the entire mesonephros. The three small panels on the right
icate negative and positive nuclei, respectively, for p21.
icated (n). Statistical significance relative to WT embryos was assessed by the
ell 155, 1104–1118, November 21, 2013 ª2013 Elsevier Inc. 1109
(legend on next page)
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upregulated a number of pathways related to proliferation and
DNA replication (Figure S4A and Table S2). On the other hand,
important developmental pathways, such as the TGF-b, Hedge-
hog, and WNT pathways, were associated with WT tubules (i.e.,
senescent) and decreased in p21 null tubules (i.e., nonsenes-
cent) (Table S3; Figure 4A). Based on the most differentially ex-
pressed genes (Figure S4B and Tables S4 and S5), we confirmed
by quantitative RT-PCR (qRT-PCR) that genes from these path-
ways are expressed at higher levels in WT tubules compared to
p21 null ones, including Bmpr1b (encoding the BMP receptor
type 1B from the TGF-b pathway), Gli1 (encoding a main tran-
scription factor mediating the Hedgehog pathway), and Nkd1
(encoding a regulator of the WNT pathway) (Figure 4B). The dif-
ferential expression of Gli1was also confirmed by immunohisto-
chemistry against GLI1 (Figure S4C). Of note, we could not
detect statistically significant similarities between the global
gene-expression profile of the senescent mesonephric epithe-
lium and previously published gene-expression signatures of se-
nescent fibroblasts induced by the infliction of DNA damage
(Lafferty-Whyte et al., 2010), replicative senescence (Kim et al.,
2013; Shelton et al., 1999), oncogene-induced senescence (Col-
lado et al., 2005; Kuilman et al., 2008), or activation of tumor sup-
pressors (Abad et al., 2007; Rovillain et al., 2011). Although
different at a global gene-expression level, senescence in meso-
nephric epithelial cells and in fibroblasts share a subset of gene-
expression changes. Most notably, the TGF-b pathway is
commonly upregulated in the senescent mesonephros and in
many types of damage/stress-induced senescence (Acosta
et al., 2013; Kuilman and Peeper, 2009).
Based on these data, we investigated the possible functional
association of the TGF-b pathway with p21-mediated devel-
opmentally programmed senescence. In particular, TGF-b
activates the transcription of the p21 gene through SMAD com-
plexes (Datto et al., 1995; Nakae et al., 2003; Reynisdo´ttir et al.,
1995). In support of this, we detected phosphorylated SMAD2
(i.e., active and nuclear) in the nuclei of the epithelial cells from
themesonephric tubules and the endolymphatic sac (Figure 4C).
To causally connect the TGF-b pathway with senescence,
we treated pregnant mice with a TGF-b pathway inhibitor
(LY2152799), selective for the main TGF-b receptor, namely
TGFBR1 or ALK5, by daily oral gavage from E10.5 to E14.5. As
a control, phospho-SMAD2 was substantially decreased upon
treatment with the TGF-b receptor inhibitor (Figure 4D). Remark-
ably, SAbG activity in the mesonephros and endolymphatic sac
was quantitatively reduced after treatment with the TGF-b
receptor inhibitor, and this was accompanied by a detectableFigure 4. Developmentally Programmed Senescence Is Associated wi
(A) GSEA plots of p21 null (n = 3) compared to WT (n = 5) microdissected meson
(B) Expression of the indicated genes by qRT-PCR in mesonephric tubules of W
(C) Staining of phosphorylated SMAD2 in the mesonephric tubules (left) and the
obtaining similar results.
(D) Mesonephric tubules and endolymphatic sac of embryos from pregnant WT
E10.5 to E14.5. Embryos were subjected to whole-mount SAbG staining and then
or pSMAD2. The graphs show the percentage of blue surface and p21-positive ce
obtained in a total of three embryos per condition, each from a separate pregna
All samples correspond to embryos at E14.5. Values are expressed as mean ± SD
0.05; **p < 0.01; ***p < 0.001.
See also Figure S4 and Tables S2, S3, S4, and S5.
Creduction in p21 (Figure 4D). We conclude that p21-mediated
developmentally programmed senescence is causally linked to
the TGF-b/SMAD pathway.
Role of the PI3K/FOXO Pathway in Developmentally
Programmed Senescence
We took note of the fact that FOXO proteins and SMAD proteins
form complexes that bind and activate the p21 promoter
(Seoane et al., 2004). Based on this, we hypothesized that the
PI3K/FOXO pathway (Greer and Brunet, 2005) could also partic-
ipate in the regulation of developmentally programmed senes-
cence. Specifically, staining for total FOXO1 revealed a mixture
of positive and negative nuclei in the endolymphatic sac at
E14.5 (Figure 5A), and we wondered whether this could be
related to the heterogeneous pattern of p21-positive and -nega-
tive cells characteristic of this structure (see Figures 2B and
S2D). To address this, we performed double immunofluo-
rescence against p21 and phosphorylated FOXO1/3 (i.e.,
inactive and cytoplasmic). Interestingly, cells with high levels of
pFOXO1/3 presented low levels of p21, and conversely, high
levels of p21 were associated with low levels of pFOXO1/3 (Fig-
ures 5A and 5B). These results are compatible with FOXO1/3
being a positive regulator of p21 in the endolymphatic sac.
To validate the implication of the PI3K/FOXO pathway, we
manipulatedPI3Kactivitybothgenetically andchemically.Wefirst
analyzed Pten-transgenic mice (ubiquitously expressing about 2-
fold levels ofPTENcompared toWTmice). Interestingly,SAbGac-
tivitywas increased in themesonephrosandendolymphaticsacof
Pten-transgenic embryos (Figure 5C), and phosphorylated AKT
levels were reduced (Figure 5C). The number of p21-positive cells
was not significantly affected in Pten-transgenic embryos (Fig-
ure S5A), suggesting that the reinforcement of senescence might
be due to an increase in the levels of p21 within senescent cells,
rather than to an increase in the number of p21-positive cells. As
an additional proof, we used a potent small compound inhibitor
of PI3K, namely CNIO-PI3Ki, which is highly specific for PI3K cat-
alytic subunits p110a and p110d (Ortega-Molina et al., 2012). The
compoundwas administered by daily oral gavage to pregnant fe-
males from E10.5 to E14.5. Interestingly, exposure to CNIO-PI3Ki
produceda remarkable quantitative increase in the SAbGsignal in
the mesonephric tubules and endolymphatic sac (Figures 5D and
5E). As in the case of Pten-transgenic mice, this treatment was
accompaniedbyadecrease in pAKT (Figure 5D) anddidnot affect
the number of p21-positive cells (Figure S5B).
In addition to FOXO activation, low PI3K activity also results
in mTOR downregulation (Zoncu et al., 2011). To explore theth the TGF-b Pathway
ephric tubules for the indicated gene sets.
T (n = 3) or p21 null (n = 3) embryos.
endolymphatic sac (right) of WT embryos. At least five embryos were stained,
females daily treated with vehicle or with a TGF-b inhibitor (LY2157299) from
counterstained with NFR or subjected to immunohistochemical staining of p21
lls in the mesonephric tubules and the endolymphatic sac. These results were
ncy.
. Statistical significance was assessed by the two-tailed Student’s t test: *p <
ell 155, 1104–1118, November 21, 2013 ª2013 Elsevier Inc. 1111
Figure 5. Inhibition of PI3K Enhances Developmentally Programmed Senescence
(A) Endolymphatic sacs of WT embryos stained for total FOXO1 and for p21 (red), pFOXO1/3 (green), and DAPI (blue). In the case of FOXO1, the black arrowhead
indicates a negative nucleus, and the white arrowhead a positive one; in the other panels, white arrowheads indicate p21-positive and pFOXO1/3-negative nuclei.
(B) Quantification of pFOXO1/3 detected by immunofluorescence, as in (A), and measured as fluorescence arbitrary units (f.a.u.).
(C) Mesonephric tubules and endolymphatic sacs of embryos of the indicated genotypes stained for SAbG. The mesonephric tubules were subsequently stained
for phosphorylated AKT.
(D) Mesonephric tubules and endolymphatic sacs of embryos from pregnant females daily treated with vehicle or with a PI3K inhibitor (CNIO-PI3Ki), from E10.5 to
E14.5, and stained for SAbG. The mesonephric tubules were subsequently stained for phosphorylated AKT.
(E) Percentage of blue surface in SAbG staining as in (D).
All samples correspond to E14.5 embryos at the indicated conditions or genotypes. Equivalent results were obtained in a total of three embryos per condition or
genotype, each from a separate pregnancy. Values are expressed as mean ± SD. Statistical significance was assessed by the two-tailed Student’s t test: *p <
0.05; **p < 0.01.
See also Figure S5.
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Figure 6. Delayed Mesonephric Regression in p21 Null Mice
(A) Histological sections stained with hematoxylin and eosin (H&E), active
caspase-3 (C3A), and EGF-like module-containing mucin-like hormone re-
ceptor-like 1 (F4/80) of themesonephros ofWT and p21 null female embryos at
E14.5. Asterisks indicate the apical tubular area, and rectangles indicate the
caudal tubular area. The bottom panels show a magnification of the caudal
tubular areas. Equivalent results were obtained in a total of three embryos per
genotype.
(B) Same as (A) but at E15.5.
(C) Percentage of mesonephric tubules with at least one C3A-positive cell at
the indicated times and genotypes. Values are expressed as mean ± SD at the
indicated number of embryos (n). Statistical significance relative to WT E14.5
tubules was assessed by the two-tailed Student’s t test: ***p < 0.001.
See also Figure S6.
Cputative relevance of mTOR, we treated pregnant females with
rapamycin under conditions that decreased phosphorylated S6
protein in the embryo (Hirota et al., 2011). However, SAbG activ-
ity in the mesonephric tubules and endolymphatic sac was
similar between rapamycin-treated and vehicle-treated embryos
(Figure S5C), thus suggesting that mTOR downregulation is not
an important mediator of developmental senescence. Finally,
the levels of pSMAD2 and FOXO1 increased from E11.5 to
E14.5, thus following the same pattern as p21 and SAbG (Fig-
ure S5D; see Figures 1C, 2B, and S2D).
In summary, through a combination of genetic and chemical
approaches, we conclude that the TGF-b/SMAD and PI3K/
FOXO pathways directly participate in developmentally pro-
grammed senescence.
Clearance of Senescent Cells and Partial Compensatory
Mechanisms in p21 Null Mice
Senescent cells can be efficiently cleared through macrophage-
mediated phagocytosis (Kang et al., 2011; Xue et al., 2007), and
macrophages are known to infiltrate the regressing meso-
nephros (Camp and Martin, 1996). We observed abundant mac-
rophages surrounding senescent mesonephric tubules at E14.5
(Figures 6A and S6A). However, macrophages were absent at
E12.5 (FigureS6A), adevelopmental stagewhenmesonephric tu-
bules are already senescent according to SAbG, p21, and Ki67
levels (see Figures 1B and 2A). This is consistent with the idea
that senescence precedes macrophage infiltration. We also
considered the possible contribution of apoptosis to the regres-
sion of the mesonephric tubules. At E14.5, most of the meso-
nephric tubuleswere free of apoptotic cells, although surrounded
by macrophages (Figure 6A). Later, at days E15.5 and E16.5,
caudal tubules had disappeared, and macrophages remained
abundant (Figures 6B, S6B, and S6C).We conclude that cells un-
dergoing developmentally programmed senescence are cleared
by macrophages in the absence of widespread apoptosis.
We wondered about the fate of the mesonephric tubules when
developmental senescence is genetically ablated. Interestingly,
themesonephros of p21 null embryos presentedminimal macro-
phage infiltration at E14.5 (Figure 6A) and did not present
increased apoptosis compared to WT mesonephros (Figures
6A and 6C). However, this situation changed on the following
day (E15.5), when apoptosis was significantly increased in the
p21 null tubules (Figure 6C) and the mesonephros became
massively infiltrated by macrophages surrounding the caudal
tubules (Figures 6B and S6B). It should be noted that at this
time, the caudal tubules of the WT mesonephros have already
disappeared, thus indicating a delayed regression of the p21
null mesonephros. At day E16.5, the mesonephric remnants of
WT and p21 null embryos were similar, lacking caudal tubules
and still being heavily infiltrated by macrophages (Figure S6C).
Therefore, the absence of senescence in p21 null mesonephric
tubules is compensated by a delayed activation of an apoptotic
program that is followed by macrophage-mediated clearance.
A similar analysis was performed in the endolymphatic sac.
Interestingly, p21 null embryos at a late stage of development
(E18.5) had a remarkably abnormal endolymphatic sac with
multiple infoldings that crossed and filled most of the lumen of
the sac (Figure S7A). However, this defect was ameliorated inell 155, 1104–1118, November 21, 2013 ª2013 Elsevier Inc. 1113
Figure 7. Developmentally Programmed Senescence in the Female Wolffian Duct and Morphologic Abnormalities in the Vaginas of p21
Null Mice
(A) Wolffian (W) and Mullerian (M) ducts at the caudal ends of the mesonephros in male or female E14.5 embryos of the indicated genotypes stained for SAbG or
Ki67, as indicated. The percentage of Ki67-positive cells in theWolffian duct epithelium at the caudal mesonephric region is shown. In the case ofWT females and
males, n = 4 per sex; in the case of p21 null females, n = 3. Values are expressed asmean ± SD. Statistical significance relative toWT female was assessed by the
two-tailed Student’s t test: **p < 0.01.
(B) External view of a septate vagina and graph with the percentages of septate vagina in WT and p21 null female littermates. The number of septate vaginas and
the total number of females examined are indicated. Statistical significance was assessed by the Fisher’s exact test.
(legend continued on next page)
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newborns (E19.5/postnatal day 0 [P0]) (Figure S7A), and it was
undetectable in adult mice (Figure S7B). In agreement with the
normalization of the endolymphatic sac, extensive hearing and
balance tests did not reveal detectable functional defects in
adult p21 null mice (Figure S7C and Table S6).
Previous investigators have reported that a minor population
of cells from the endolymphatic sac undergo a robust expansion
after E14.5 (Kim andWangemann, 2011). These cells are charac-
terized by the expression of pendrin, an anion transporter, also
known as SLC26A4, important for the outflow of the endolymph
at the sac of the inner ear. We hypothesized that the role of
senescence at the endolymphatic sac is to arrest the major pop-
ulation of cells present at E14.5 in favor of the minor pendrin-
positive population. Indeed, we observed a lack of colocalization
of p21-positive cells and pendrin-positive cells, indicating that
they constitute different cell populations (Figure S7D). Interest-
ingly, at E18.5, pendrin-positive cells were underrepresented in
p21 null embryos compared to WT (Figure S7E). These observa-
tions suggest that an important biological function of senes-
cence at the endolymphatic sac is to regulate the balance
between different cell populations.
Finally, we asked about themechanisms that correct the aber-
rant morphology of the p21 null endolymphatic sac at perinatal
stages. For this, we stained E18.5 embryos and E19.5/P0 peri-
natal mice for SAbG, caspase-3 (C3A), and macrophages (F4/
80) (Figure S7F). Most of the infoldings present in p21 null
sacs, and to a lower extent in WT sacs, had apoptotic cells
and macrophage infiltration in the absence of senescence (Fig-
ure S7F). We interpret that the elimination of endolymphatic
sac infoldings, both in WT and p21 null embryos, is a macro-
phage-dependent remodeling process that occurs during late
development independently of senescence.
In summary, we conclude that developmentally programmed
senescence can play at least two roles: elimination of structures
through macrophage-dependent clearance, as in the case of
the mesonephric tubules, and determination of the balance be-
tween cell populations, as in the case of the endolymphatic
sac. In the absence of developmentally programmed senes-
cence, compensatory mechanisms can correct these defective
morphogenic processes, either by apoptosis, as observed in
the mesonephros, or through a general remodeling mediated
by macrophages, as observed in the endolymphatic sac.
Morphological Abnormalities in p21 Null Mice
In the case of the mesonephros, the only structure that does not
undergo complete regression is theWolffian duct. Specifically, in
the case of males, the Wolffian duct proliferates and differenti-
ates into the epididymis and the vas deferens (Davidson,
2008). In contrast, most of the femaleWolffian duct degenerates,
with the notable exception of the caudal portion that participates
in the formation of the vagina (Kurita, 2010; Orvis and Behringer,(C) Histological analyses of transversal sections of normal and septate vaginas fr
septum.
(D) Mean number of pups per female of the indicated genotypes. The total num
statistical significance was assessed by the two-tailed Student’s t test.
(E) Summary of the molecular mechanisms regulating developmentally programm
See also Figure S7, Table S6, and Movies S1 and S2.
C2007). Importantly, the different behavior of the Wolffian duct in
males (expansion) and females (partial regression) correlated
with senescence at E14.5 (Figure 7A). In the case of males,
hardly any SAbG activity was present in the Wolffian duct at
the caudal mesonephros, whereas SAbG was present in the fe-
male Wolffian duct. Also, the male Wolffian duct had a higher
percentage of Ki67-positive cells compared to the female Wolff-
ian duct (Figure 7A). In line with our previous findings, senes-
cence was dependent on p21, as inferred by the absence of
SAbG activity and high Ki67 levels in the Wolffian duct of p21
null females (Figure 7A). These results demonstrate that p21-
dependent senescence occurs specifically in the female, but
not in the male, Wolffian duct.
We wondered whether the absence of senescence in p21 null
females had an impact on the morphogenesis of the vagina.
Interestingly, we observed that up to 15% of the adult p21 null
females had a visible dorsoventral vaginal septum (Figure 7B).
Septate vaginas were confirmed by histology (Figure 7C) and
by ultrasound imaging (Movies S1 and S2). These septa were
also found in a small percentage of WT females (3.75%), which
is in agreement with a previous report on the incidence of septate
vagina in laboratory mice (Cunliffe-Beamer and Feldman, 1976).
Vaginal septa are known to reduce fertility, due in part to mucus
accumulation and associated infectious processes that may
affect the viability of the fetuses (Lezmi et al., 2011). Indeed,
p21 null females had a lower number of pups compared to WT
females (Figure 7D). Together, these results indicate that defec-
tive programmed senescence in the Wolffian duct of p21 null fe-
males results in an increased incidence of vaginal septa, thus
compromising fertility.
DISCUSSION
Essential Role of p21 in Developmentally Programmed
Senescence
Here, we report that cellular senescence occurs at multiple loca-
tions during mammalian embryonic development. We have
analyzed in detail the biological mechanisms and developmental
significance of senescence in the regressingmesonephros and in
the endolymphatic sac of the inner ear. Developmentally
programmed senescence in these structures was defined by
the presence of SAbG activity, heterochromatin markers
(H3K9me3, HP1g), and proliferative arrest (exclusion of Ki67). A
number of senescence effectors were found expressed in the
mesonephros and endolymphatic sac, namely p53, p21, p27,
and p15. However, extensive genetic analyses indicated that
only p21 was critical for developmental senescence at the stud-
ied structures (Figure 7E). Also, we could not detect evidence for
DNA-damagemarkers in the senescent cells of themesonephros
and endolymphatic sac, nor an involvement of theDNA-damage-
signaling kinases ATM or ATR. Therefore, developmentallyom adult females of the indicated genotypes. Arrowheads point to the vaginal
ber of litters examined is indicated. Values are expressed as mean ± SD, and
ed senescence.
ell 155, 1104–1118, November 21, 2013 ª2013 Elsevier Inc. 1115
programmed senescence is characterized by its dependency on
p21 and by the absence of obvious damage signals.
Signaling Pathways Regulating Developmentally
Programmed Senescence
Gene-expression analysis in the mesonephros suggested the
upregulation of the TGF-b, Hedgehog, and WNT pathways in
developmental senescence. We focused on the TGF-b pathway
because of its previous involvement in senescence (Acosta et al.,
2013; Kuilman and Peeper, 2009) and its well-established
capacity to activate the transcription of the p21 gene through
SMAD complexes (Datto et al., 1995; Nakae et al., 2003; Reynis-
do´ttir et al., 1995). We found high levels of phospho-SMAD2
(i.e., active) in the epithelia of the mesonephros and endolym-
phatic sac. Interestingly, treatment of pregnant females with a
TGF-b pathway inhibitor significantly reduced SAbG activity
and p21 levels, thus demonstrating a direct impact of the TGF-
b pathway on p21-mediated senescence. TGF-b-activated
SMAD proteins are known to act in concert with FOXO proteins
(Seoane et al., 2004) and, based on this, we examined the impact
of the PI3K/FOXO pathway on p21-mediated senescence. In
particular, genetic overexpression of Pten, which is a positive
regulator of FOXO through inhibition of PI3K, and treatment of
pregnant females with a PI3K inhibitor resulted in stronger
senescence at the mesonephros and endolymphatic sac. Alto-
gether, we conclude that the TGF-b/SMAD and PI3K/FOXO
pathways are involved in p21-mediated developmentally pro-
grammed senescence (Figure 7E).
We find it remarkable that two separate developmental pro-
cesses share not only the same critical effector, namely p21,
but also the same regulatory pathways. Based on this, it is
tempting to speculate that thesemechanisms could be common
to other processes of developmental senescence. In this regard,
it is important to mention that the accompanying paper shows
that p21 has been also involved in senescence during neural
tube closure and digit formation (Storer et al., 2013).
Clearance of Senescent Cells and Compensatory
Mechanisms
Emerging evidence indicates that tumoral cells that undergo
damage-induced senescence are ultimately cleared by macro-
phages (Kang et al., 2011; Xue et al., 2007). Interestingly, we
observed that macrophages infiltrate and surround the senes-
cent mesonephric tubules, which are efficiently eliminated at
day E15.5. The recruitment of macrophages by senescent cells
is a complex process incompletely understood (Hoenicke and
Zender, 2012), where TGF-b plays a relevant role (Flavell et al.,
2010). In contrast, senescence is absent and macrophage infil-
tration is negligible in p21 null embryos at E14.5. A day later,
the mesonephric tubules of WT embryos have disappeared,
whereas those of p21 null remain essentially intact. Nonetheless,
p21 null tubules are efficiently eliminated by E16.5 through a
compensatory process that involves apoptosis and massive
macrophage infiltration. Therefore, in the case of the meso-
nephros, senescence behaves as the primary signal that triggers
macrophage-mediated elimination, but, if senescence fails, a
delayed apoptotic program can also accomplish mesonephric
involution.1116 Cell 155, 1104–1118, November 21, 2013 ª2013 Elsevier Inc.The endolymphatic sac, in contrast to themesonephros, is not
eliminated during development, but it undergoes a process of
differential arrest and expansion of selective cell populations.
This is exemplified by the expansion of pendrin-positive cells
that occurs after E14.5 (Kim and Wangemann, 2011). In the
case of p21 null embryos, the endolymphatic sac presents an
abnormal expansion of pendrin-negative cells presumably as a
consequence of the lack of senescence. This unbalanced cell
ratio is accompanied by numerous aberrant infoldings that fill
the lumen of the sac. However, at late stages of development,
the few papillae present in WT sacs, as well as the numerous
ones in p21 null sacs, undergo a general process of elimination
associated with macrophage infiltration independently of senes-
cence. Therefore, we conclude that the biological function of
senescence at the endolymphatic sac is to establish a correct
balance between cell populations.
The observation that other processes can compensate
deficient senescence is not surprising given the robustness of
embryonic development. In relation to this, for example, severe
disabling of apoptosis results in relatively minor developmental
defects, restricted to imperforate vaginas and a partial persis-
tence of interdigital webs (Lindsten et al., 2000; Ren et al.,
2010). Curiously, the formation of the vagina and the digits are
two morphogenic processes that involve senescence (our cur-
rent work; Storer et al., 2013). This could reflect a more general
trend whereby senescence and apoptosis are mutually compen-
satory and interconnected during developmental processes.
Developmental Defects Associated with Impaired
Programmed Senescence
Despite the compensatory processes mentioned above, we
wondered whether the failure to undergo senescence could
affect adult structures. We observed that the female Wolffian
duct is almost completely eliminated during normal development
except for its contribution to the caudal region of the vagina
(Kurita, 2010; Orvis and Behringer, 2007). This is in contrast to
the male Wolffian duct that expands and differentiates into the
vas deferens and epididymis. Notably, during mesonephric invo-
lution, the femaleWolffian duct undergoes p21-mediated senes-
cence, whereas the male Wolffian duct remains proliferative.
We examined the vaginas of adult p21 null females and found
a remarkable incidence of septa, which is consistent with an
abnormal contribution of the Wolffian ducts to the formation of
the vagina, and this was accompanied by a reduced fertility.
Therefore, at least in the case of the mesonephros and its
derived structures, compensatory processes do not fully replace
the absence of developmentally programmed senescence. We
anticipate the existence of other mediators of senescence that,
together with p21, may contribute to developmental senes-
cence, and their combined inactivationmay result inmore severe
morphogenic defects.
Concluding Remarks
In summary, our findings expand the biology of cellular
senescence from stress responses associated with patho-
logical states, cancer, and aging to morphological processes
during embryonic development in mammals. Developmentally
programmed senescence is a physiological process that occurs
predictably and reproducibly in response to developmental
cues, whereas, in contrast, damage/stress-induced senescence
is triggered by nonphysiological insults or pathological states.
We have focused on two developmental processes associated
with senescence, and interestingly, both of them shared the
same mechanistic principles, including the implication of the
TGF-b/SMAD and PI3K/FOXO pathways and the critical role of
p21. Importantly, senescence features are also present in human
embryos.
Conceptually, we add cellular senescence to the collection of
processes that contribute to embryonic development, together
with proliferation, differentiation, migration, and cell death. This
opens up the possibility that cellular senescence originated in
evolution as a tissue-remodeling mechanism during embryonic
development, and it was subsequently adapted to orchestrate
tissue regeneration andhealing upondamage in adult organisms.
EXPERIMENTAL PROCEDURES
Mice
All animal procedures were performed according to protocols approved by the
CNIO-ISCIII Ethics Committee for Research and Animal Welfare (CEIyBA).
Human Samples
Human embryos were obtained by A.R.-B. from spontaneous abortions
voluntarily donated by the mother to hospitals affiliated with the Universitat
Auto`noma de Barcelona, under signed informed consent following the ethical
procedures of the corresponding hospitals.
Treatment with Chemical Inhibitors
Pregnant females were treated by daily oral gavage, from days E10.5 to E14.5,
with the following compounds: LY2157299 (25 mg/kg) (Axon MedChem);
CNIO-PI3Ki (15 mg/kg) (Ortega-Molina et al., 2012); and rapamycin
(20 mg/kg) (LC laboratories). Mice were sacrificed 6 hr after the last dose
and processed for histological analyses. For additional details, see the
Extended Experimental Procedures.
Statistical Analyses
All quantitative data are presented as mean ± SD. Two-tailed Student’s t test
was carried out to assess statistical significance, unless otherwise indicated.
Accesion Numbers
The microarray data have been deposited in the Gene Expression Omnibus
(GEO) database (http://www.ncbi.nlm.nih.gov/geo/) under the accession
number GSE49108.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, six tables, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2013.10.019.
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